Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-01-07 @ 7:13 AM
Study NCT ID:
NCT02067767
Status:
COMPLETED
Last Update Posted:
2016-02-22
First Post:
2014-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)
Sponsor:
Nantes University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-18
First Submit QC Date:
None
Study First Post Date:
2014-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-19
Last Update Post Date:
2016-02-22
Last Update Post Date Type:
ESTIMATED